Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CSL
CSL
Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing
Endpoints
Thu, 12/16/21 - 11:53 pm
Vifor Pharma
CSL
M&A
Biopharma’s buyout year ends with a bang
EP Vantage
Wed, 12/15/21 - 10:37 am
M&A
CSL
Vifor Pharma
Pfizer
Arena Pharmaceuticals
As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report
Endpoints
Mon, 12/13/21 - 11:02 am
M&A
Vifor Pharma
CSL
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Fierce Pharma
Wed, 08/25/21 - 09:32 pm
Takeda
CSL
hereditary angiodema
HAE
RWE
Takhzyro
Cinryze
Haegarda
UniQure/CSL hit by FDA clinical hold for hem B gene therapy program after liver cancer find
Fierce Biotech
Mon, 12/21/20 - 11:09 am
uniQure
CSL
FDA
clinical trials
hemophilia B
gene therapy
etranacogene dezaparvovec
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
Endpoints
Wed, 11/18/20 - 11:07 pm
Pharvaris
HAE
Takeda
CSL
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
BioPharma Dive
Sat, 10/10/20 - 11:27 pm
clinical trials
plasma
COVID-19
Takeda
CSL
UniQure out-licenses hemophilia B gene therapy in deal valued up to ~$2.1B
Seeking Alpha
Wed, 06/24/20 - 11:29 pm
uniQure
CSL
hemophilia B
etranacogene dezaparvovec
Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process
BioPharma Dive
Wed, 04/8/20 - 10:33 am
Takeda
CSL
COVID-19
plasma
drug development
Want to win over payers, pharma? Forget the 'me-too' drugs, CSL chief says
Fierce Pharma
Tue, 01/15/19 - 11:06 am
CSL
Paul Perreault
me-too drugs
payers
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Fierce Pharma
Thu, 06/21/18 - 12:02 pm
CSL
HAE
Shire
Cinryze
Haegarda
CSL revamps branding to recruit employees, partners
Fierce Pharma
Mon, 03/5/18 - 03:01 pm
CSL
branding
CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
Endpoints
Mon, 08/28/17 - 09:29 am
CSL
Calimmune
M&A
stem cells
FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
Endpoints
Fri, 06/23/17 - 09:48 am
FDA
CSL
HAE
hereditary angiodema
Shire
Haegarda
Firazyr
Kalbito
Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch
Fierce Pharma
Mon, 04/17/17 - 04:10 pm
Shire
rare disease
CSL
patents
Haegarda
HAE
hereditary angiodema
Hemophilia marketing tactics raise questions as market heats up
Fierce Pharma
Thu, 01/14/16 - 08:47 pm
hemophilia
drug marketing
Biogen
CSL
Bayer
Roche
First flu vaccine with immune-boosting adjuvant approved for US market
Stat
Wed, 11/25/15 - 11:35 am
flu vaccines
vaccines
immune-boosting adjuvants
Fluad
CSL
Novartis
Seqirus
How Does Novavax Compare to Its Competitors?
Yahoo/Market Realist
Mon, 08/31/15 - 11:18 am
Novavax
Inovio
iBio
CSL
Sinovac
Biota
Novartis jettisons flu vaccine
Seeking Alpha
Mon, 10/27/14 - 07:55 am
Novartis
flu vaccine
vaccines
CSL
CSL’s potential new treatment for heart disease could boost profits further
Motley Fool
Wed, 11/27/13 - 08:53 am
CSL
Pages
« first
‹ previous
1
2
3
4
next ›
last »